Order
Laboratory Industry Strategic Outlook: Niche/Specialty Markets
$1,095.00
Licenses Available
If you wish to receive a pdf file of this report, which can be distributed to others within your organization or posted to an intranet for firm-wide use, please contact our Licensing & Permissions director, Jonathan Wentworth-Ping at jping@G2Intelligence.com or call 973-718-4703. |
Laboratory Industry Strategic Outlook: Niche/Specialty Markets
A must-have for laboratories and health systems in the U.S., Laboratory Industry Strategic Outlook: Niche/Specialty Markets
offers the proprietary data and analysis needed to successfully compete in three critical, high-growth markets: Allergy/Immunology Testing, Genetic Testing, and Cancer (Oncology) Testing.
In this comprehensive volume, you’ll get revenue trends and projections through 2013, details on market size and the regulatory landscape of each market, as well as critical case studies
that will help you answer crucial questions like:
- What are the demand trends of today’s niche markets?
- Which are the best markets to enter?
- Who are the major players in each market?
With Laboratory Industry Strategic Outlook: Niche/Specialty Markets, you’ll get the market intelligence you need to make informed decisions about emerging opportunities for your lab, reduce the risk of business investments tied to these markets, and empower your sales force and marketing campaigns to drive success.
Key takeaways in each market include:
Allergy/Immunology Testing
- Modalities
- Market size, trends and pricing
- Exclusive laboratory profiles
Genetic Testing
- Testing and regulatory landscape
- Cytogenetics – market size & exclusive laboratory profiles
- Preimplantation Genetic Diagnosis (PGD) —reimbursement, competition, market size, issues related to proficiency and quality assurance, and exclusive laboratory profiles.
Cancer (Oncology) Testing
- Modalities, market size and reimbursement
- AP revenue growth at 10 national pathology companies
- Challenges facing the anatomic pathology market
- Four cancer biomarker case studies
- Profiles of 32 major laboratories performing oncology testing
Order now to receive your copy for just $1,095 and your state's sales tax.
|